Skip to content
Mebeverine 135 mg & Chlordiazepoxide 5 mg is a specialized pharmaceutical formulation designed to alleviate various gastric issues and provide targeted relief. This medication is recommended for conditions such as Irritable Bowel Syndrome (IBS), ulcers, and inflammation within the digestive tract. Mebeverine acts as an antispasmodic, calming the muscles in the digestive system and reducing discomfort, while Chlordiazepoxide, known for its tranquilizing properties, helps to manage anxiety often associated with digestive disorders. This potent combination improves overall digestive health and facilitates better gastrointestinal functionality. Manufactured with precision, the product is available for export and supply worldwide for healthcare practitioners focused on treating complex gastric ailments effectively.
| Drug Type | Other Types |
| Ingredients | Clidinium Bromide 2.5 mg & Chlordiazepoxide 5 mg |
| Physical Form | Tablets |
| Function | Treat Gastric Issues |
| Recommended For | IBS, Ulcers, Digestive Tract Inflammation |
| Minimum Order Quantity | 15-30 Boxes |
| Supply Ability | 100000 Boxes Per Month |
| Delivery Time | 4 Week |
| Packaging Details | Blister, 4*5*10 |
| Main Export Market(s) | Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa, Asia |
| Main Domestic Market | All India |
| Certifications | WHO-GMP |
It is recommended for Irritable Bowel Syndrome (IBS), ulcers, and digestive tract inflammation.
Mebeverine provides relief from muscle spasms in the digestive system, while Chlordiazepoxide manages anxiety commonly associated with gastric issues.
Yes, this product is available for export, manufacturing, and supply.
Yes, the combination of Mebeverine and Chlordiazepoxide enhances digestive health and functionality effectively.
Patients suffering from IBS, ulcers, or inflammation of the digestive tract can benefit from this medication.
